
Psychiatr Serv 51:216-222, February 2000
© 2000 American Psychiatric Association
Predicting Medication Noncompliance After Hospital Discharge Among Patients With Schizophrenia
Mark Olfson, M.D., M.P.H.,
David Mechanic, Ph.D.,
Stephen Hansell, Ph.D.,
Carol A. Boyer, Ph.D.,
James Walkup, Ph.D. and
Peter J. Weiden, M.D.
OBJECTIVE: The study sought to identify predictors of noncompliance with medication in a cohort of patients with schizophrenia after discharge from acute hospitalization. METHODS: Adult psychiatric inpatients with schizophrenia or schizoaffective disorder for whom oral antipsychotics were prescribed (N=213) were evaluated at hospital discharge and three months later to assess medication compliance. Comparisons were made between patients who reported stopping their medications for one week or longer and patients who reported more continuous medication use. RESULTS: Of the 213 patients, about a fifth (19.2 percent) met the criterion for noncompliance. Medication noncompliance was significantly associated with an increased risk of rehospitalization, emergency room visits, homelessness, and symptom exacerbation. Compared with the compliant group, the noncompliant group was significantly more likely to have a history of medication noncompliance, substance abuse or dependence, and difficulty recognizing their own symptoms. Patients who became medication noncompliant were significantly less likely to have formed a good therapeutic alliance during hospitalization as measured by inpatient staff reports and were more likely to have family members who refused to become involved in their treatment. CONCLUSIONS: Patients with schizophrenia at high risk for medication noncompliance after acute hospitalization are characterized by a history of medication noncompliance, recent substance use, difficulty recognizing their own symptoms, a weak alliance with inpatient staff, and family who refuse to become involved in inpatient treatment.
This article has been cited by other articles:

|
 |

|
 |
 
R. Mojtabai, L. Fochtmann, S.-W. Chang, R. Kotov, T. J. Craig, and E. Bromet
Unmet Need for Mental Health Care in Schizophrenia: An Overview of Literature and New Data From a First-Admission Study
Schizophr Bull,
July 1, 2009;
35(4):
679 - 695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Fischer, J. C. McSweeney, J. M. Pyne, D. K. Williams, A. J. Naylor, F. C. Blow, and R. R. Owen
Influence of Family Involvement and Substance Use on Sustained Utilization of Services for Schizophrenia
Psychiatr Serv,
August 1, 2008;
59(8):
902 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. I. Velligan, P. M. Diamond, J. Mintz, N. Maples, X. Li, J. Zeber, L. Ereshefsky, Y.-W. F. Lam, D. Castillo, and A. L. Miller
The Use of Individually Tailored Environmental Supports to Improve Medication Adherence and Outcomes in Schizophrenia
Schizophr Bull,
May 1, 2008;
34(3):
483 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Marcus and M. Olfson
Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
Schizophr Bull,
January 1, 2008;
34(1):
173 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Olfson, S. C. Marcus, and H. Ascher-Svanum
Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
Schizophr Bull,
November 1, 2007;
33(6):
1379 - 1387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Singh, A. J. Massey, M. D. Thompson, L. R. Rappa, and M. S. Honeywell
Addressing Nonadherence in the Schizophrenic Population
Journal of Pharmacy Practice,
December 1, 2006;
19(6):
361 - 368.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Linden, T. Scheel, and F.-X. Eich
Improvement of patient compliance after switching from conventional neuroleptics to the atypical neuroleptic amisulpride
J Psychopharmacol,
November 1, 2006;
20(6):
815 - 823.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. I. Velligan, Y.-W. F. Lam, D. C. Glahn, J. A. Barrett, N. J. Maples, L. Ereshefsky, and A. L. Miller
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Schizophr Bull,
October 1, 2006;
32(4):
724 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Pyne, J. McSweeney, H. S. Kane, S. Harvey, L. Bragg, and E. Fischer
Agreement Between Patients With Schizophrenia and Providers on Factors of Antipsychotic Medication Adherence
Psychiatr Serv,
August 1, 2006;
57(8):
1170 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Compton, B. E. Rudisch, J. Craw, T. Thompson, and D. A. Owens
Predictors of Missed First Appointments at Community Mental Health Centers After Psychiatric Hospitalization
Psychiatr Serv,
April 1, 2006;
57(4):
531 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. E. BARNES, S. H. MUTSATSA, S. B. HUTTON, H. C. WATT, and E. M. JOYCE
Comorbid substance use and age at onset of schizophrenia
The British Journal of Psychiatry,
March 1, 2006;
188(3):
237 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Olfson, S. C. Marcus, J. Wilk, and J. C. West
Awareness of Illness and Nonadherence to Antipsychotic Medications Among Persons With Schizophrenia
Psychiatr Serv,
February 1, 2006;
57(2):
205 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Medalia and R. Richardson
What Predicts a Good Response to Cognitive Remediation Interventions?
Schizophr Bull,
October 1, 2005;
31(4):
942 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Hovens, P. J. T. Dries, C. T. M. Melman, R. J. C. Wapenaar, and A. J. M. Loonen
Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study
J Psychopharmacol,
January 1, 2005;
19(1):
51 - 57.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Gilmer, C. R. Dolder, J. P. Lacro, D. P. Folsom, L. Lindamer, P. Garcia, and D. V. Jeste
Adherence to Treatment With Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries With Schizophrenia
Am J Psychiatry,
April 1, 2004;
161(4):
692 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Rittmannsberger, T. Pachinger, P. Keppelmuller, and J. Wancata
Medication Adherence Among Psychotic Patients Before Admission to Inpatient Treatment
Psychiatr Serv,
February 1, 2004;
55(2):
174 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. O'Donnell, G. Donohoe, L. Sharkey, N. Owens, M. Migone, R. Harries, A. Kinsella, C. Larkin, and E. O'Callaghan
Compliance therapy: a randomised controlled trial in schizophrenia
BMJ,
October 11, 2003;
327(7419):
834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Thieda, S. Beard, A. Richter, and J. Kane
An Economic Review of Compliance With Medication Therapy in the Treatment of Schizophrenia
Psychiatr Serv,
April 1, 2003;
54(4):
508 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kozuki and E. S. Froelicher
Lack of Awareness and Nonadherence in Schizophrenia
West J Nurs Res,
February 1, 2003;
25(1):
57 - 74.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Dolder, J. P. Lacro, and D. V. Jeste
Adherence to Antipsychotic and Nonpsychiatric Medications in Middle-Aged and Older Patients With Psychotic Disorders
Psychosom Med,
January 1, 2003;
65(1):
156 - 162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zygmunt, M. Olfson, C. A. Boyer, and D. Mechanic
Interventions to Improve Medication Adherence in Schizophrenia
Am J Psychiatry,
October 1, 2002;
159(10):
1653 - 1664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Patel, P. G. Dorson, N. Edwards, S. Mendelson, and M. L. Crismon
One-Year Rehospitalization Rates of Patients Discharged on Atypical Versus Conventional Antipsychotics
Psychiatr Serv,
July 1, 2002;
53(7):
891 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Magura, A. B. Laudet, D. Mahmood, A. Rosenblum, and E. Knight
Adherence to Medication Regimens and Participation in Dual-Focus Self-Help Groups
Psychiatr Serv,
March 1, 2002;
53(3):
310 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Dolder, J. P. Lacro, L. B. Dunn, and D. V. Jeste
Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?
Am J Psychiatry,
January 1, 2002;
159(1):
103 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|